JP5114397B2 - ヒアルロン酸リン脂質複合体及びその調製法 - Google Patents

ヒアルロン酸リン脂質複合体及びその調製法 Download PDF

Info

Publication number
JP5114397B2
JP5114397B2 JP2008520696A JP2008520696A JP5114397B2 JP 5114397 B2 JP5114397 B2 JP 5114397B2 JP 2008520696 A JP2008520696 A JP 2008520696A JP 2008520696 A JP2008520696 A JP 2008520696A JP 5114397 B2 JP5114397 B2 JP 5114397B2
Authority
JP
Japan
Prior art keywords
hyaluronic acid
phospholipid
complex
acid
phospholipids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2008520696A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009500503A5 (cg-RX-API-DMAC7.html
JP2009500503A (ja
Inventor
リン、ペイシュエ
ホワン、シリン
ルー、ホンシャン
チャン、ティエンミン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of JP2009500503A publication Critical patent/JP2009500503A/ja
Publication of JP2009500503A5 publication Critical patent/JP2009500503A5/ja
Application granted granted Critical
Publication of JP5114397B2 publication Critical patent/JP5114397B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pulmonology (AREA)
  • Toxicology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
JP2008520696A 2005-07-13 2006-07-12 ヒアルロン酸リン脂質複合体及びその調製法 Expired - Fee Related JP5114397B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CNA2005100440676A CN1742623A (zh) 2005-07-13 2005-07-13 透明质酸磷脂复合物及其制备方法
CN200510044067.6 2005-07-13
PCT/CN2006/001652 WO2007006232A1 (fr) 2005-07-13 2006-07-12 Complexe de phospholipide et d’acide hyaluronique et procédé de préparation

Publications (3)

Publication Number Publication Date
JP2009500503A JP2009500503A (ja) 2009-01-08
JP2009500503A5 JP2009500503A5 (cg-RX-API-DMAC7.html) 2009-08-27
JP5114397B2 true JP5114397B2 (ja) 2013-01-09

Family

ID=36138272

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008520696A Expired - Fee Related JP5114397B2 (ja) 2005-07-13 2006-07-12 ヒアルロン酸リン脂質複合体及びその調製法

Country Status (3)

Country Link
JP (1) JP5114397B2 (cg-RX-API-DMAC7.html)
CN (1) CN1742623A (cg-RX-API-DMAC7.html)
WO (1) WO2007006232A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2921253B1 (fr) * 2007-09-26 2012-11-16 Lvmh Rech Composition cosmetique sous la forme d'une emulsion comprenant une phase aqueuse continue et une phase grasse dispersee et son procede de preparation
CA2703532C (en) * 2010-05-10 2018-05-01 Eva Turley Topically administered, skin-penetrating glycosaminoglycan formulations suitable for use in cosmetic and pharmaceutical applications
CN118766082A (zh) * 2023-12-29 2024-10-15 黑龙江飞鹤乳业有限公司 组合物、食品及其应用
CN121370848A (zh) * 2025-12-25 2026-01-23 哈药集团技术中心 一种含有右莰醇的药物组合物及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ320006A (en) * 1995-10-23 2001-12-21 Meditech Res Ltd An adjuvant composition comprising hyaluronic acid for gene therapy either in the sense or antisense direction
JP3687277B2 (ja) * 1997-06-10 2005-08-24 サンスター株式会社 美白化粧料
US7141552B2 (en) * 2000-01-10 2006-11-28 Yissum Research Development Company Of The Hebrew University Of Jerusalem Use of lipid conjugates in the treatment of diseases
JP4521809B2 (ja) * 2004-04-16 2010-08-11 生化学工業株式会社 歯周疾患の検定方法および検定用キット
US8178129B2 (en) * 2004-11-02 2012-05-15 Tel-Aviv University Future Technology Development L.P. Formulations of water insoluble or poorly water soluble drugs in lipidated glycosaminoglycan particles and their use for diagnostic and therapy
ITPD20050146A1 (it) * 2005-05-20 2006-11-21 Fidia Farmaceutici Fillers riassorbibili costituiti da liposomi e acido ialuronico e o suoi derivati

Also Published As

Publication number Publication date
CN1742623A (zh) 2006-03-08
WO2007006232A1 (fr) 2007-01-18
JP2009500503A (ja) 2009-01-08

Similar Documents

Publication Publication Date Title
Keller Liposomes in nutrition
JP5695308B2 (ja) コラーゲン修飾リポソームからなる化粧料基剤およびそれを含有する皮膚化粧料
EP0514506B1 (en) Lipid formulation system
BRPI0908686B1 (pt) Método de produção de nanopartículas não-imunogênicas, nanopartícula nãoimunogênica terapeuticamente ativa, composição terapêutica, uso de uma nanopartícula nãoimunogênica e kit para a produção de nanopartículas não-imunogênicas
TR201903899T4 (tr) Demir eksikliği durumlarında kullanıma yönelik demir içeren katı bileşim.
EP2209468A1 (en) Sustained-release chitosan capsules comprising chitosan and phytic acid
JP5429642B2 (ja) 薬剤の局所導出を対象とした注射可能なポリマー/脂質ブレンド
JPH06502158A (ja) Dnaゲル中に安定化された温泉水のリポソーム
EP3654938A1 (en) Powder solid dispersions comprising quercetin, process for their preparation and formulations thereof
Dwivedi et al. Progressive journey of phytosomes: preparation, characterization, patents, clinical trials & commercial products
JP2025500619A (ja) 皮膚吸収増進のための陽イオン性リポソーム、及びその製造方法
KR102722951B1 (ko) 단층 리포좀에서 친수성 화합물의 고효율 캡슐화
WO2018020903A1 (ja) 皮膚外用剤
JP2009521400A (ja) ヒアルロン酸リン脂質合成物を含む経口関節機能改善と保護剤
KR101775266B1 (ko) 신규한 트라넥사민산 담지 액정나노입자 및 그의 제조방법
JP2009500503A (ja) ヒアルロン酸リン脂質複合体及びその調製法
KR20210040512A (ko) 경피투과펩티드 및 인지질 리포좀 복합체에 의한 hapln1의 피부흡수증진 조성물
Kucuk et al. Incorporation of biologically active ingredient gallic acid into nano-scale lipid vesicles
KR101034567B1 (ko) 탈모 방지 및 발모 촉진용 약물 전달 시스템
KR102224224B1 (ko) 식용 가능한 시트형 물품
JP3249583B2 (ja) リポソーム製剤
KR20210115591A (ko) 트라넥사민산 담지 경피전달시스템 및 그의 제조방법
IT201800008192A1 (it) Microsfere di acido ialuronico reticolato con urea e contenenti almeno un agente attivo o farmaco
US12629335B2 (en) Chitosomes or chitosan-coated liposomes, use thereof to obtain cosmetic or pharmaceutical compositions and preparation method thereof
KR100831627B1 (ko) 수용성 생리활성 성분을 포집한 역상 다중층 베시클

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090708

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20090708

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120529

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120829

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20120829

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20120921

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20121015

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20151019

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees